Table 3.

Dermatomyositis in association with autoimmune blistering diseases in the present literature

Case	Citation	AIBD	Age, years	Sex	Timing of DM diagnosis	DM type	Treatment	Associated malignancy
1	Narbutt, 2003	PF	11	Male	2 years earlier	Juvenile	Prednisolone; hydroxychloroquine; cyclosporine; methotrexate; cyclophosphamide	None
2	Black and Marshman, 2011	PV	76	Female	40 months earlier	Classic	Prednisolone; methotrexate	None
3	Thongprasom et al., 2013	PV	36	Female	4 years later	Amyopathic	Prednisolone; dapsone; chloroquine; methotrexate; colchicine; celecoxib	None
4	Fujimoto et al., 2014	PF	39	Female	29 months earlier	Amyopathic	Topical steroidal agents	None
5	Present case	PV	51	Female	8 months later	Classic	Prednisone	None
6	Glover and Leigh, 1992	BP	65	M	Simultaneously	Classic	Prednisolone; azathioprine
7	Tsukada, 2003	BP	70	Male	8 months later	Classic	Prednisolone; methotrexate; minocycline	None
8	Yanagi et al., 2007	BP	81	Female	Simultaneously	Classic	Topical steroidal agents	Colon carcinoma
9	Garcia et al., 2017	BP	69	Female	Simultaneously	Amyopathic + ILD	Prednisolone; rituximab	Gastric MALT lymphoma
10	Present case	MMP	82	Male	5 years later	Amyopathic + ILD	Prednisone; dapsone; mycophenolate mofetil	None
11	Barrows-Wade and Jordon, 1992	Linear IgA dermatosis	56	Female	Simultaneously	Classic	Dapsone; prednisolone	None
12	White, 1982	DH	67	Female	3 years earlier	Classic		None
13	Kalovidouris et al., 1989	DH	34	Male	7 years later	Classic	Dapsone; prednisolone	None
14	Kalovidouris et al., 1989	DH	33	Male	4 years later	Classic		None

AIBD, autoimmune bullous disease; BP, bullous pemphigoid; DH, dermatitis herpetiformis; DM, dermatomyositis; Ig, immunoglobulin; ILD, interstitial lung disease; MALT, mucosa-associated lymphoid tissue; MMP, mucous membrane pemphigoid; PF, pemphigus foliaceus; PV, pemphigus vulgaris